Literature DB >> 26116991

Meta-Analysis of Non-O Blood Group as an Independent Risk Factor for Coronary Artery Disease.

Hisato Takagi1, Takuya Umemoto2.   

Abstract

To determine whether non-O blood group is an independent risk factor for coronary artery disease (CAD), we performed a meta-analysis of contemporary studies reporting adjusted relative risk estimates using multivariable logistic regression and multivariable Cox proportional hazards regression. MEDLINE and EMBASE were searched from January 2001 to March 2015 using Web-based search engines (PubMed and OVID). Search terms included blood group/type and coronary (artery/heart) disease, ischemic/ischaemic heart disease, acute coronary syndrome, myocardial infarction, or angina. Eligible were case-control, cross-sectional, or cohort studies reporting adjusted odds ratios (ORs) and hazard ratios (HRs) for CAD in subjects with non-O versus O blood group using multivariable logistic regression/multivariable Cox proportional hazards regression. Study-specific estimates were combined using inverse variance-weighted averages of logarithmic ORs/HRs in the random-effects model. Of 117 potentially relevant articles screened initially, 12 relative risk estimates in 10 eligible studies were identified and included. Pooled analysis of all the 12 ORs/HRs demonstrated that non-O blood group was associated with a statistically significant 14% increase in CAD incidence relative to O blood group (OR/HR 1.14, 95% confidence interval 1.04 to 1.25, p = 0.006). There was no evidence of significant publication bias. Combining 8 studies reporting data regarding (acute) myocardial infarction also generated a statistically significant result unfavoring non-O blood group (OR/HR 1.16, 95% confidence interval 1.02 to 1.31, p = 0.02). In conclusion, we found that based on a meta-analysis of 10 studies enrolling a total of 174,945 participants, non-O blood group appears to be an independent risk factor for CAD and myocardial infarction.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26116991     DOI: 10.1016/j.amjcard.2015.05.043

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Glycan structures and their recognition roles in the human blood group ABH/Ii, Lea, b, x, y and Sialyl Lea,x active cyst glycoproteins.

Authors:  Albert M Wu
Journal:  Glycoconj J       Date:  2019-11-26       Impact factor: 2.916

Review 2.  ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis.

Authors:  Zhuo Chen; Sheng-Hua Yang; Hao Xu; Jian-Jun Li
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

3.  Relation of ABO Blood Groups to the Plaque Characteristic of Coronary Atherosclerosis.

Authors:  Xingtao Huang; Yongpeng Zou; Lulu Li; Shuyuan Chen; Jingbo Hou; Bo Yu
Journal:  Biomed Res Int       Date:  2017-11-08       Impact factor: 3.411

4.  Association of ABO blood groups with the severity of coronary artery disease: a cross-sectional study.

Authors:  Xu-Lin Hong; Ya Li; Guo-Sheng Fu; Heng Wu; Yao Wang; Chun-Xia Gu; Wen-Bin Zhang
Journal:  J Geriatr Cardiol       Date:  2019-09       Impact factor: 3.327

5.  Replication and Characterization of Association between ABO SNPs and Red Blood Cell Traits by Meta-Analysis in Europeans.

Authors:  Stela McLachlan; Claudia Giambartolomei; Jon White; Pimphen Charoen; Andrew Wong; Chris Finan; Jorgen Engmann; Tina Shah; Micha Hersch; Clara Podmore; Alana Cavadino; Barbara J Jefferis; Caroline E Dale; Elina Hypponen; Richard W Morris; Juan P Casas; Meena Kumari; Yoav Ben-Shlomo; Tom R Gaunt; Fotios Drenos; Claudia Langenberg; Diana Kuh; Mika Kivimaki; Rico Rueedi; Gerard Waeber; Aroon D Hingorani; Jacqueline F Price; Ann P Walker
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

6.  Blood Group Types O and Non-O Are Associated With Coronary Collateral Circulation Development.

Authors:  Savas Celebi; Ozlem Ozcan Celebi; Berkten Berkalp; Sinan Aydogdu; Basri Amasyali
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.